Novonesis
Manufacturing · Denmark · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Krogshoejvej 36, Bagsvaerd, Region Hoved...Website
www.novonesis.comRevenue
$4.8 BillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Novonesis
Novonesis, founded in 2024 through the merger of Novozymes and Chr. Hansen, is a global biosolutions company that leverages microbiology, enzymes, and fermentation technologies to help industries improve efficiency, sustainability, and product performance. The company serves sectors including food, agriculture, healthcare, energy, and industrial manufacturing. They focus on developing science-based biological solutions that support healthier lives, more sustainable production processes, and reduced environmental impact across global markets.Explore more
Novonesis Org Chart
Get the full picture
Sign in to uncover key details.
MM
Director, Gbs Corporate Shared Services
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Novonesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Novonesis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Novonesis is spiking on competitors!
Funding: Get notified immidiatlly once Novonesis has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Novonesis had a recent Job posting/layoffs
Check if Novonesis has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Novonesis
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Novonesis launches new products
Earning: See what the market has to say on Novonesis recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Novonesis as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Novonesis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Novonesis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novonesis.
Novonesis Tech Stack
A closer look at the technologies used by Novonesis
Most Recent Scoops
Earnings
Novonesis has indicated that H2 organic sales growth will be impacted by three factors, the reversal of a one-time Q1 inventory build-up in the animal segment, partial tariff reimbursements being passed back to customers, and only slight growth expected in the human health segment.
Sales
Earnings
Novonesis has announced an interim dividend of DKK 2.35 per share for H1 of 2026, to be dispersed on 27 August 2026, with 24 August 2026 as the last trading day with dividend.
Earnings
Novonesis has reported organic sales growth of 7% in its Planetary Health Biosolutions division for H1 of the year and 9% in Q2, with an adjusted EBITDA margin of 38.8% in H1 of 2026, up 40 basis points year over year, driven by the Feed Enzyme Alliance acquisition and cost synergies, partially offset by increased commercial resources and currency headwinds.
Earnings, Acquisitions, Finance
Earnings
Novonesis has noted that H2 organic sales growth will be impacted by the reimbursement of US tariffs to customers, representing a minor negative effect included in the full-year outlook, and that the Q1 inventory build-up at a key customer in the animal business will be neutral for the full year, with high comparables expected in Q3.
Sales, Logistics / Supply Chain, Inventory Management, Finance, Tax
Earnings
Earnings, Acquisitions, Business Finance, Finance
Novonesis News & Media
Novonesis (Novozymes) B's Dividend Analysis
Novonesis (Novozymes) B (NVZMY) recently announced a total dividend of $0.37 per share, with the ex-dividend date set for 2026-08-31. This includes a $0.37 per share cash dividend payable on 2026-09-16. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communitiesTop Five Procurement Stories: PepsiCo, Accenture, Genesys
This week’s top five features PepsiCo’s sustainable procurement, Accenture’s multi-year AI initiative with Dabur, Genesys’s emissions target and moreH1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
COPENHAGEN, Denmark – August 19, 2026. Novonesis delivered strong first half of 2026 at 8% organic sales growth. 2026 outlook: Organic sales growth increased to 7-8% (previously 5-7%), and the adjusted EBITDA margin expected at the higher end of the 37-38% range. Inaugural share buy-back program announced.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Novonesis
Sign Up For FreeTo access detailed company insights
Novonesis, founded in 2024 through the merger of Novozymes and Chr. Hansen, is a global biosolutions company that leverages microbiology, enzymes, and fermentation technologies to help industries improve efficiency, sustainability, and product performance. The company serves sectors including food, agriculture, healthcare, energy, and industrial ma... Read More
